◆英語タイトル：Aimmune Therapeutics Inc (AIMT) - Financial and Strategic SWOT Analysis Review
Aimmune Therapeutics Inc (Aimmune) formerly Allergen Research Corp is a clinical-stage biopharmaceutical company that develops proprietary product candidates for the treatment of peanut and other food allergies. The company’s lead product candidate AR101 is used to treat the peanut allergy. Its pipeline program portfolio uses characterized oral desensitization immunotherapy (CODIT), a proprietary approach to oral immunotherapy. Aimmune discovers, develops and commercializes therapies related to food allergy. The company conducts academic research in partnership with various universities and other companies to develop novel product candidates. The company operates in the US and the UK. Aimmune is headquartered in Brisbane, California, the US.
Aimmune Therapeutics Inc Key Recent Developments
Feb 28,2019: Aimmune Therapeutics announces fourth quarter and full year 2018 financial results and provides recent operational highlights
Feb 25,2019: Aimmune Therapeutics Presents New AR101 Data at AAAAI Including Demonstrated Reduction in Accidental Exposures to Peanut Requiring Treatment
Feb 04,2019: Aimmune Therapeutics to Present AR101 OIT and Peanut Allergy Data at 2019 AAAAI Annual Meeting
Jan 18,2019: Aimmune Therapeutics Appoints Andrew Oxtoby as Chief Commercial Officer
This comprehensive SWOT profile of Aimmune Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aimmune Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Aimmune Therapeutics Inc – Key Information
Aimmune Therapeutics Inc – Overview
Aimmune Therapeutics Inc – Key Employees
Aimmune Therapeutics Inc – Key Employee Biographies
Aimmune Therapeutics Inc – Key Operational Heads
Aimmune Therapeutics Inc – Major Products and Services
Aimmune Therapeutics Inc – History
Aimmune Therapeutics Inc – Company Statement
Aimmune Therapeutics Inc – Locations And Subsidiaries
Aimmune Therapeutics Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Aimmune Therapeutics Inc – Business Description
Aimmune Therapeutics Inc – Corporate Strategy
Aimmune Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Aimmune Therapeutics Inc – Strengths
Aimmune Therapeutics Inc – Weaknesses
Aimmune Therapeutics Inc – Opportunities
Aimmune Therapeutics Inc – Threats
Aimmune Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Aimmune Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Aimmune Therapeutics Inc, Key Information
Aimmune Therapeutics Inc, Key Ratios
Aimmune Therapeutics Inc, Share Data
Aimmune Therapeutics Inc, Major Products and Services
Aimmune Therapeutics Inc, History
Aimmune Therapeutics Inc, Key Employees
Aimmune Therapeutics Inc, Key Employee Biographies
Aimmune Therapeutics Inc, Key Operational Heads
Aimmune Therapeutics Inc, Other Locations
Aimmune Therapeutics Inc, Subsidiaries
Aimmune Therapeutics Inc, Key Manufacturing facilities
Aimmune Therapeutics Inc, Key Competitors
Aimmune Therapeutics Inc, SWOT Analysis
Aimmune Therapeutics Inc, Ratios based on current share price
Aimmune Therapeutics Inc, Annual Ratios
Aimmune Therapeutics Inc, Interim Ratios
Capital Market Ratios
List of Figures
Aimmune Therapeutics Inc, Performance Chart
Aimmune Therapeutics Inc, Ratio Charts
| ★海外企業調査レポート[Aimmune Therapeutics Inc (AIMT)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら